| Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery JO Eloy, MC de Souza, R Petrilli, JPA Barcellos, RJ Lee, JM Marchetti Colloids and surfaces B: Biointerfaces 123, 345-363, 2014 | 547 | 2014 |
| Immunoliposomes: A review on functionalization strategies and targets for drug delivery JO Eloy, R Petrilli, LNF Trevizan, M Chorilli Colloids and Surfaces B: Biointerfaces 159, 454-467, 2017 | 195 | 2017 |
| Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy JO Eloy, R Petrilli, JF Topan, HMR Antonio, JPA Barcellos, DL Chesca, ... Colloids and Surfaces B: Biointerfaces 141, 74-82, 2016 | 141 | 2016 |
| Delivery systems and local administration routes for therapeutic siRNA FTMC Vicentini, LN Borgheti-Cardoso, LV Depieri, D de Macedo Mano, ... Pharmaceutical research 30, 915-931, 2013 | 126 | 2013 |
| EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles E da Silva Santos, KAB Nogueira, LCC Fernandes, JRP Martins, ... International journal of pharmaceutics 592, 120082, 2021 | 119 | 2021 |
| Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy JO Eloy, R Petrilli, DL Chesca, FP Saggioro, RJ Lee, JM Marchetti European journal of pharmaceutics and biopharmaceutics 115, 159-167, 2017 | 114 | 2017 |
| Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection R Petrilli, JO Eloy, FP Saggioro, DL Chesca, MC de Souza, MVS Dias, ... Journal of controlled release 283, 151-162, 2018 | 100 | 2018 |
| Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models FSG Praça, WSG Medina, JO Eloy, R Petrilli, PM Campos, A Ascenso, ... European Journal of Pharmaceutical Sciences 111, 121-132, 2018 | 97 | 2018 |
| Liquid crystalline nanodispersions functionalized with cell-penetrating peptides for topical delivery of short-interfering RNAs: a proposal for silencing a pro-inflammatory … R Petrilli, JO Eloy, FSG Praça, JO Del Ciampo, MAC Fantini, ... Journal of biomedical nanotechnology 12 (5), 1063-1075, 2016 | 60 | 2016 |
| EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells JO Eloy, A Ruiz, FT de Lima, R Petrilli, G Raspantini, KAB Nogueira, ... Colloids and Surfaces B: Biointerfaces 194, 111185, 2020 | 51 | 2020 |
| Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells R Petrilli, J O Eloy, R FV Lopez, R J Lee Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 50 | 2017 |
| Physical methods for topical skin drug delivery: concepts and applications R Petrilli, RFV Lopez Brazilian Journal of Pharmaceutical Sciences 54 (spe), e01008, 2018 | 47 | 2018 |
| Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries ELC Cruz-Cazarim, MS Cazarim, AT Ogunjimi, R Petrilli, EM Rocha, ... European Journal of Pharmaceutics and Biopharmaceutics 140, 1-10, 2019 | 39 | 2019 |
| Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells J O Eloy, R Petrilli, R W Brueggemeier, J Maldonado Marchetti, R J Lee Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 39 | 2017 |
| Liquid crystal nanodispersions enable the cutaneous delivery of photosensitizer for topical PDT: fluorescence microscopy study of skin penetration F Silva Garcia Praca, W Silva Garcia Medina, R Petrilli, ... Current Nanoscience 8 (4), 535-540, 2012 | 38 | 2012 |
| Nanoparticles of lyotropic liquid crystals: A novel strategy for the topical delivery of a chlorin derivative for photodynamic therapy of skin cancer R Petrilli, F SG Praca, AR H Carollo, W SG Medina, KT de Oliveira, ... Current Nanoscience 9 (4), 434-441, 2013 | 34 | 2013 |
| The prominence of the dosage form design to treat ocular diseases PM Campos, R Petrilli, RFV Lopez International Journal of Pharmaceutics 586, 119577, 2020 | 29 | 2020 |
| Targeted liposomes for siRNA delivery to cancer JO Eloy, R Petrilli, GL Raspantini, RJ Lee Current Pharmaceutical Design 24 (23), 2664-2672, 2018 | 27 | 2018 |
| Targeted lipid nanoparticles for antisense oligonucleotide delivery R Petrilli, J O Eloy, J M Marchetti, R FV Lopez, R J Lee Current Pharmaceutical Biotechnology 15 (9), 847-855, 2014 | 27 | 2014 |
| Liposome-based nanocarrier loaded with a new quinoxaline derivative for the treatment of cutaneous leishmaniasis JK de Oliveira, T Ueda-Nakamura, AG Correa, R Petrilli, RFV Lopez, ... Materials Science and Engineering: C 110, 110720, 2020 | 26 | 2020 |
